Enanta Pharmaceuticals, Inc. · NASDAQ:ENTA

Deep Track Capital, LP reported a 5.33% stake in Enanta Pharmaceuticals, Inc. (Schedule 13G)

Event Oct 2, 2025 · Filed Oct 9, 2025

Deep Track Capital, LP reported a 5.33% stake in Enanta Pharmaceuticals, Inc., 1,484,513 shares, as a passive investor on Oct 2, 2025. Filed Oct 9, 2025 (Schedule 13G).

Stake
5.33%
Shares
1,484,513
Intent
Passive
What changed
Crossed above 5%
Filed together
3 holders

The filing in full

HolderStakeShares
Deep Track Capital, LP5.33%1,484,513
Deep Track Biotechnology Master Fund, Ltd.5.33%1,484,513
David Kroin5.33%1,484,513

Source

View original at SEC

Related